Literature DB >> 321176

Effect of triamterene on potassium excretion in cirrhotic patients receiving furosemide.

E J Thompson, E Torres, S J Grosberg, M Martinez-Maldonado.   

Abstract

In a three-way crossover study, 23 patients with hepatic cirrhosis, ascites, and dependent edema received 40 mg/day of furosemide alone and combined with triamterene 50 mg/day and triamterine 100 mg/day. Baseline potassium excretion did not increase when furosemide was given alone, but potassium excretion fell when 50 mg or 100 mg of triamterene was also given. Both doses of triamterene augmented the natriuretic effect of furosemide.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 321176     DOI: 10.1002/cpt1977214392

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  2 in total

1.  Pharmacokinetics of triamterene and its metabolite in man.

Authors:  J Hasegawa; E T Lin; R L Williams; F Sörgel; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1982-10

2.  Treatment for ascites in adults with decompensated liver cirrhosis: a network meta-analysis.

Authors:  Amine Benmassaoud; Suzanne C Freeman; Davide Roccarina; Maria Corina Plaz Torres; Alex J Sutton; Nicola J Cooper; Laura Iogna Prat; Maxine Cowlin; Elisabeth Jane Milne; Neil Hawkins; Brian R Davidson; Chavdar S Pavlov; Douglas Thorburn; Emmanuel Tsochatzis; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2020-01-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.